INHIBITOREN VON KREBS UND/ODER METASTASIS
European patent · EP3538101 · In force
Register entry
- Publication number
- EP3538101
- Application number
- EP17868916
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 14, 2017
- Published
- Sep 18, 2019
- Granted
- Jun 19, 2024
- Protection ends at the latest
- Nov 13, 2037
- Next annual fee due
- Nov 30, 2026
- IPC classes
- C07D 487/04 (2006.01)A61K 31/519 (2006.01)A61P 35/00 (2006.01)
- Priority
- US 201662421468 P 14.11.2016US 201662424571 P 21.11.2016
- PCT application
- PCT/US2017/061443 14.11.2017
- PCT publication
- WO2018/089967 17.05.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 27, 2026
Change
Published in Swissreg on 27.03.2026
- Apr 30, 2025
Change
Published in Swissreg on 30.04.2025
- Dec 9, 2024
Change
Published in Swissreg on 09.12.2024
- Sep 23, 2024
Agent entered
- Representative
- HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel
Published in Swissreg on 23.09.2024
- Jun 19, 2024
Granted
Published in Swissreg on 19.06.2024
Parties
Holder
Inventor
Richmond VA 23298, US
Riverside CA 92521, US
Richmond VA 23298, US
Richmond VA 23298, US
Richmond VA 23298, US
Richmond VA 23298, US
Richmond VA 23298, US
La Jolla CA 92037, US
Henrico VA 23238, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.